These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8980758)

  • 1. Antibiotic susceptibility of the newly cultivated agent of human granulocytic ehrlichiosis: promising activity of quinolones and rifamycins.
    Klein MB; Nelson CM; Goodman JL
    Antimicrob Agents Chemother; 1997 Jan; 41(1):76-9. PubMed ID: 8980758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis.
    Brouqui P; Raoult D
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2799-803. PubMed ID: 1482148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial susceptibility of Ehrlichia phagocytophila.
    Horowitz HW; Hsieh TC; Aguero-Rosenfeld ME; Kalantarpour F; Chowdhury I; Wormser GP; Wu JM
    Antimicrob Agents Chemother; 2001 Mar; 45(3):786-8. PubMed ID: 11181361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
    Visalli MA; Jacobs MR; Appelbaum PC
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Ehrlichia sennetsu to antibiotics.
    Brouqui P; Raoult D
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1593-6. PubMed ID: 2221869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis.
    Klein MB; Hayes SF; Goodman JL
    Infect Immun; 1998 Jul; 66(7):3410-5. PubMed ID: 9632613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis.
    Klein MB; Miller JS; Nelson CM; Goodman JL
    J Infect Dis; 1997 Nov; 176(5):1405-9. PubMed ID: 9359749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antimicrobial in vitro activities against Streptococcus pneumoniae independent of MIC susceptibility breakpoints using MIC frequency distribution curves, scattergrams and linear regression analyses.
    Fass RJ; Barnishan J
    J Antimicrob Chemother; 2001 Nov; 48(5):609-15. PubMed ID: 11679549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of Mycoplasma hominis clinical isolates to tetracyclines, quinolones and macrolides.
    Samra Z; Rosenberg S; Soffer Y
    Diagn Microbiol Infect Dis; 2002 Dec; 44(4):359-61. PubMed ID: 12543541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
    Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):362-6. PubMed ID: 8834881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1.
    Barnewall RE; Ohashi N; Rikihisa Y
    Infect Immun; 1999 May; 67(5):2258-65. PubMed ID: 10225882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct cultivation of the causative agent of human granulocytic ehrlichiosis.
    Goodman JL; Nelson C; Vitale B; Madigan JE; Dumler JS; Kurtti TJ; Munderloh UG
    N Engl J Med; 1996 Jan; 334(4):209-15. PubMed ID: 8531996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the human granulocytic ehrlichiosis agent based on analysis of rRNA isolated from control and infected HL-60 cells.
    Wu JM; Whyzmuzis CA; Bertone MG; Zhou BS; Hsieh TC
    Biochem Biophys Res Commun; 1999 Aug; 262(1):7-13. PubMed ID: 10448059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.
    Ravyn MD; Goodman JL; Kodner CB; Westad DK; Coleman LA; Engstrom SM; Nelson CM; Johnson RC
    J Clin Microbiol; 1998 Jun; 36(6):1480-8. PubMed ID: 9620365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia.
    Lotric-Furlan S; Petrovec M; Zupanc TA; Nicholson WL; Sumner JW; Childs JE; Strle F
    Clin Infect Dis; 1998 Sep; 27(3):424-8. PubMed ID: 9770134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
    Dubois J; St-Pierre C
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Ryan BM; Mazzucco CE; Lawrence LE; Ho H; Warr G; Barrett JF; Frosco M
    Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):27-34. PubMed ID: 11913498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE).
    Hsieh TC; Aguero-Rosenfeld ME; Wu JM; Ng C; Papanikolaou NA; Varde SA; Schwartz I; Pizzolo JG; Melamed M; Horowitz HW; Nadelman RB; Wormser GP
    Biochem Biophys Res Commun; 1997 Mar; 232(2):298-303. PubMed ID: 9125168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is human granulocytic ehrlichiosis a new Lyme disease? Review and comparison of clinical, laboratory, epidemiological, and some biological features.
    Dumler JS
    Clin Infect Dis; 1997 Jul; 25 Suppl 1():S43-7. PubMed ID: 9233663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.